Abstract
Although dephosphorylation of tyrosine containing proteins is considered a necessary step in the induction of leukemia cell differentiation by hybrid polar compounds (HPC), the crucial actors in this step remain unknown. We present evidence that tyrosine phosphorylation of JAK1 and JAK2 is down-regulated in murine erythroleukemia cells (MELC) within the first 6 h of their exposure to the prototype of the HPC family, hexamethylenebisacetamide (HMBA), with full recovery at 14 h. Further evidence that the JAKs-centered signalling pathway is switched off early by HMBA was provided by the demonstration that STAT5, a downstream member of this pathway, turned out to be completely dephosphorylated at 6 h in HMBA-treated cells. This JAKs dephosphorylation did not occur in HMBA-resistant clones, suggesting that JAKs are possible targets of the dephosphorylative process required for leukemia cell commitment to differentiation. These results may have impact on leukemia therapy based on JAKs inhibitors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Reuben RC, Rifkind RA, Marks PA . Chemically induced murine erythroleukemic differentiation Biochim Biophys Acta 1980 605: 325–346
Marks PA, Rifkind RA . Differentiating factors. In: DeVita VT, Hellman SH, Rosenberg SA (eds) Biologic Therapy of Cancer Lippincott: Philadelphia 1991 pp. 754–762
Rifkind RA, Richon VM, Marks PA . Induced differentiation, the cell cycle, and the treatment of cancer Pharmacol Ther 1996 69: 97–102
Arcangeli A, Carlà M, Del Bene R, Becchetti A, Wanke E, Olivotto M . Polar/apolar compounds induce leukemia cell differentiation by modulating cell-surface potential Proc Natl Acad Sci USA 1993 90: 5858–5862
Carlà M, Cuomo M, Arcangeli A, Olivotto M . Adsorption properties of polar/apolar inducers at a charged interface and their relevance to leukemia cell differentiation Biophys J 1995 68: 2615–2621
Olivotto M, Arcangeli A, Carlà M, Wanke E . Electric fields at the plasma membrane level: a neglected element in the mechanisms of cell signalling BioEssays 1996 18: 495–504
Watanabe T, Kume T, Oishi M . Alteration of phosphotyrosine-containing proteins at the early stage of erythroid differentiation of mouse erythroleukemia (MEL) cells J Biol Chem 1992 267: 17116–17120
Watanabe T, Kondo K, Oishi M . Induction of in vitro differentiation of mouse erythroleukemia cells by genistein, an inhibitor of tyrosine protein kinases Cancer Res 1991 51: 764–768
Kume T, Tsuneizumi K, Watanabe T, Thomas M, Oishi M . Induction of specific protein tyrosine phosphatase transcripts during differentiation of mouse erythroleukemia cells J Biol Chem 1994 269: 4709–4712
Ihle JN . Cytokine receptor signalling Nature 1995 377: 591–594
Li J-P, D'Andrea AD, Lodish HF, Baltimore D . Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor Nature 1990 343: 762–764
Ferro FE, Kozak SL, Hoatlin ME, Kabat D . Cell surface site for mitogenic interaction of erythropoietin receptors with the membrane glycoprotein encoded by Friend erythroleukemia virus J Biol Chem 1993 268: 5741–5747
Yamamura Y ., Senda H, Kageyama Y, Matsuzaki T, Noda M, Ikawa Y. Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells Mol Cell Biol 1998 18: 1172–1180
Meydan N, Grunberger T, Shahar M, Arpaia E, Lapidot Z, Leeder JS, Freedman M, Choen A, Gazit A, Roifman CM . Inhibition of acute lymphoblastic leukemia by a JAK-2 inhibitor Nature 1996 379: 645–648
Wakao H, Chida D, Damen JE, Krystal G, Miyajima A . A possible involvement of STAT5 in erythropoietin-induced hemoglobin synthesis. Biochem Biophys Res Commun 1997 234: 198–205
Yamascita T, Wakao H, Miyajima A, Asano S . Differentiation inducers modulate cytokine signalling pathways in a murine erythroleukemia cell line Cancer Res 1998 58: 556–561
Arcangeli A, Ricupero L, Olivotto M . Commitment to differentiation of murine erythroleukemia cells involving a modulated plasma membrane depolarization through Ca2+ activated K+ channels J Cell Physiol 1987 132: 387–400
Fallani A, Arcangeli A, Ruggieri S . Characteristics of ether-linked glycerophospholipids in Friend erythroleukemia cells differentiated by dimethylsulfoxide or hexamethylenebisacetamide and in non-inducible clones treated with the inducers Biochem J 1988 252: 917–920
Orkin SH, Harosi FI, Leder P . Differentiation in erythroleukemic cells and their somatic hybrids Proc Natl Acad Sci USA 1975 72: 98–102
Laemli UK . Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 1970 227: 680–685
Fiorucci G, Percario ZA, Marcolin C, Coccia EM, Affabris E, Romeo G . Inhibition of protein phosphorylation modulates expression of the JAK family protein tyrosine kinases J Virol 1995 69: 5833–5837
Yamamura Y, Noda M, Ikawa Y . Activated Ki-Ras complements erythropoietin signalling in CTLL-2 cells, inducing tyrosine phosphorylation of a 160-kDa protein Proc Natl Acad Sci USA 1994 91: 8866–8870
Teglund S, McKay C, Schuetz E, Van Deursen JM, Stravopodis D, Wang D, Brown M, Bodner S, Grosveld G, Ihle JN . STAT5a and STAt5b proteins have essential and nonessential, or redundant, roles in cytokine responses Cell 1998 93: 841–850
Marks PA, Shefferey M, Rifkind RA . Induction of transformed cells to terminal differentiation and the modulation of gene expression Cancer Res 1987 47: 659–666
Bull BS, Breton-Gorius J, Beutler E . Morphology of the Erythron. In: Williams WJ, Beutler E, Erslev AJ, Lichtman MA (eds) Hemathology, 4th edn McGraw-Hill: New York 1990 297–316
Smith MR, Duhé RJ, Liu Y-L, Farrar WL . Microinjected cDNA encoding JAK2 protein-tyrosine kinase induces DNA synthesis in NIH 3T3 cells FEBS Lett 1997 408: 327–330
Marks PA, Richon VM, Kiyokawa H, Rifkind R . Inducing differentiation of transformed cells with hybrid polar compounds: a cell cycle-dependent process Proc Natl Acad Sci USA 1994 91: 10251–10254
Acknowledgements
This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro (AIRC), Associazione Italiana contro le Leucemie (AIL) Firenze, Ministero dell'Università e della Ricerca Scientifica e Tecnologica (MURST). The authors are indebted to Dr RA Rifkind, chairman of the Sloan-Kettering Institute of New York, for support and advice. The authors are grateful to Prof A Fonnesu and Dr Persio Dello Sbarba for helpful suggestions, and to Marco Cutrì for skilful technical assistance. The authors are also grateful to Dr P Bernabei for help and advice in the morphological examination of MELC.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Arcangeli, A., Fontana, L., Crociani, O. et al. A transient dephosphorylation of JAK1 and JAK2 characterises the early-phase response of murine erythroleukemia cells to the differentiation inducer hexamethylenebisacetamide. Leukemia 14, 2112–2117 (2000). https://doi.org/10.1038/sj.leu.2401936
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401936